Make your money go further for just 25p per day

AIM IHT

Fabulous results here

Fever-Tree

AIM’s premium mixer business brought a wild share price ride to holders on the day of its results, while elsewhere there were fabulous results from one of our Stonking Small Cap opportunities as well as encouraging results from a favourite for IHT planning portfolios. Read on here for this and other news. 


Fevertree Drinks: mixed outlook, but…

Results from Fevertree Drinks (AIM:FEVR) for its financial year ending to 31 December 2021 were in-line with previous guidance, although there were a couple of surprises to encourage and disappoint in terms of the outlook. The shares had a wild day selling off to begin with only to bounce back in the afternoon.

Group revenue for the year rose 23% to £311m, with particularly strong growth in…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alpha Group International

Stonking Small Caps: staggering numbers

20/03/2024 · Company Insights

With a growing product offering and expansion overseas, this founder-led business remains an exciting prospect and continues…


Episode 2 of the Investor’s Champion Podcast

20/01/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee run through key news from the stock market. It's…


More on Eagle Eye Solutions

Flush with cash | Special dividends | Corporate undertakers

25/07/2024 · Company Insights

News covered here includes our assessment of updates and results from an eclectic mix of elderly…


Fast growers | Big dividends

19/03/2024 · Company Insights

We reflect here on announcements from very different companies. While one has the appeal of very strong growth,…


More on Fevertree Drinks

Episode 33 of the Investor’s Champion Podcast

15/09/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Lee and Chris focus on news from…


US growth | Legal winner | Dividend delights

13/09/2024 · Company Insights

News covered here includes our assessment of interim results from Fevertree, which disappointed the market, despite…


More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP